Lis GJ et al. |
Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. |
2016 |
Pol. Arch. Med. Wewn. |
pmid:27003233
|
Cervellati C et al. |
Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. |
2016 |
Oxid Med Cell Longev |
pmid:26635910
|
Xing R et al. |
Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. |
2016 |
Int. J. Mol. Med. |
pmid:27599586
|
Sasso GR et al. |
Elevated serum osteoprotegerin levels in women: friend or foe? |
2015 Nov-Dec |
Rev Assoc Med Bras (1992) |
pmid:26841162
|
Calasans-Maia MD et al. |
Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814461
|
Jianru YI et al. |
Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814456
|
SaÄŸlam M et al. |
Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. |
2015 Jan-Feb |
J Appl Oral Sci |
pmid:25760266
|
Esteghamati A et al. |
Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. |
2015 Aug-Sep |
Arch Cardiovasc Dis |
pmid:26184866
|
Widschwendter M et al. |
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. |
2015 |
EBioMedicine |
pmid:26629528
|
de Molon RS et al. |
OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. |
2015 |
J. Bone Miner. Res. |
pmid:25727550
|